Yu Sakurai

9.4k total citations · 2 hit papers
128 papers, 7.8k citations indexed

About

Yu Sakurai is a scholar working on Molecular Biology, Biomaterials and Materials Chemistry. According to data from OpenAlex, Yu Sakurai has authored 128 papers receiving a total of 7.8k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Molecular Biology, 32 papers in Biomaterials and 20 papers in Materials Chemistry. Recurrent topics in Yu Sakurai's work include RNA Interference and Gene Delivery (44 papers), Nanoparticle-Based Drug Delivery (30 papers) and Advanced biosensing and bioanalysis techniques (18 papers). Yu Sakurai is often cited by papers focused on RNA Interference and Gene Delivery (44 papers), Nanoparticle-Based Drug Delivery (30 papers) and Advanced biosensing and bioanalysis techniques (18 papers). Yu Sakurai collaborates with scholars based in Japan, United States and Czechia. Yu Sakurai's co-authors include Teruo Okano, Kazunori Kataoka, M. Yokoyama, Hideyoshi Harashima, Hidetaka Akita, Akira Ohtomo, Yuko Yoshida, Glen S. Kwon, M. Kawasaki and Takao Aoyagi and has published in prestigious journals such as ACS Nano, Immunity and Applied Physics Letters.

In The Last Decade

Yu Sakurai

127 papers receiving 7.6k citations

Hit Papers

Mg x Zn 1−x O as a II–VI widegap semiconductor alloy 1998 2026 2007 2016 1998 2014 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yu Sakurai Japan 36 2.3k 2.3k 2.2k 1.6k 1.4k 128 7.8k
Dehai Liang China 40 1.7k 0.7× 1.4k 0.6× 1.4k 0.6× 1.7k 1.1× 1.5k 1.1× 170 5.6k
Eun Chul Cho South Korea 34 2.0k 0.9× 4.2k 1.9× 1.6k 0.7× 1.4k 0.9× 3.2k 2.4× 90 10.0k
Haruma Kawaguchi Japan 39 1.0k 0.4× 1.7k 0.7× 1.1k 0.5× 2.0k 1.3× 1.5k 1.1× 161 5.9k
Stephanie Hoeppener Germany 42 1.3k 0.5× 1.8k 0.8× 897 0.4× 2.3k 1.5× 1.8k 1.4× 222 6.5k
Alexander Kros Netherlands 50 2.6k 1.1× 1.4k 0.6× 3.8k 1.7× 1.3k 0.8× 1.8k 1.3× 196 7.8k
Takehiko Ishii Japan 46 2.2k 0.9× 1.5k 0.7× 3.4k 1.5× 826 0.5× 1.5k 1.1× 200 7.4k
Bradley D. Olsen United States 50 2.3k 1.0× 2.5k 1.1× 1.3k 0.6× 2.7k 1.7× 1.7k 1.3× 215 8.6k
Yao Lin United States 38 1.5k 0.7× 3.1k 1.4× 1.4k 0.6× 2.5k 1.6× 1.2k 0.9× 91 6.4k
Kensuke Osada Japan 47 2.5k 1.1× 1.0k 0.5× 3.3k 1.5× 1.4k 0.9× 1.7k 1.2× 136 6.9k
Curtis W. Frank United States 59 2.4k 1.0× 2.6k 1.1× 2.5k 1.1× 3.0k 1.9× 3.5k 2.6× 285 12.6k

Countries citing papers authored by Yu Sakurai

Since Specialization
Citations

This map shows the geographic impact of Yu Sakurai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Sakurai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Sakurai more than expected).

Fields of papers citing papers by Yu Sakurai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu Sakurai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Sakurai. The network helps show where Yu Sakurai may publish in the future.

Co-authorship network of co-authors of Yu Sakurai

This figure shows the co-authorship network connecting the top 25 collaborators of Yu Sakurai. A scholar is included among the top collaborators of Yu Sakurai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu Sakurai. Yu Sakurai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Yi, et al.. (2024). Lymphatic Endothelial Cells Produce Chemokines in Response to the Lipid Nanoparticles Used in RNA Vaccines. Biological and Pharmaceutical Bulletin. 47(3). 698–707. 4 indexed citations
2.
Sakurai, Yu, et al.. (2023). Logistics and distribution of small extracellular vesicles from the subcutaneous space to the lymphatic system. Journal of Controlled Release. 361. 77–86. 6 indexed citations
3.
Tanaka, Hiroki, Yu Sakurai, Yuta Nakai, et al.. (2023). Development of an Alcohol Dilution–Lyophilization Method for the Preparation of mRNA-LNPs with Improved Storage Stability. Pharmaceutics. 15(7). 1819–1819. 15 indexed citations
4.
Sakurai, Yu, Yi Liu, Hiroki Tanaka, et al.. (2023). Tolerogenic Lipid Nanoparticles for Delivering Self-Antigen mRNA for the Treatment of Experimental Autoimmune Encephalomyelitis. Pharmaceuticals. 16(9). 1270–1270. 11 indexed citations
6.
Tanaka, Hiroki, Yuta Nakai, Kota Tange, et al.. (2023). Development of a Ready-to-Use-Type RNA Vaccine Carrier Based on an Intracellular Environment-Responsive Lipid-like Material with Immune-Activating Vitamin E Scaffolds. Pharmaceutics. 15(12). 2702–2702. 5 indexed citations
8.
Sakurai, Yu, et al.. (2017). Failure of active targeting by a cholesterol-anchored ligand and improvement by altering the lipid composition to prevent ligand desorption. International Journal of Pharmaceutics. 536(1). 42–49. 6 indexed citations
9.
Hyodo, Mamoru, Yu Sakurai, Hidetaka Akita, & Hideyoshi Harashima. (2014). “Programmed packaging” for gene delivery. Journal of Controlled Release. 193. 316–323. 20 indexed citations
10.
Hayashi, Yasuhiro, et al.. (2013). A liposomal delivery system that targets liver endothelial cells based on a new peptide motif present in the ApoB-100 sequence. International Journal of Pharmaceutics. 456(1). 195–201. 24 indexed citations
11.
Ohuchi, Noriaki, et al.. (2008). . Nihon Nyugan Kenshin Gakkaishi (Journal of Japan Association of Breast Cancer Screening). 17(1). 15–21. 2 indexed citations
12.
Sakurai, Yu & Satoshi Sato. (2002). Automatic Generation of Term Explanation from the World Wide Web. 43(5). 1470–1480. 4 indexed citations
13.
Yokoyama, M., Fukashi Kohori, K. Sakai, et al.. (1999). Cytotoxic activity control of thermo-responsive polymeric micelle for local hyperthermia. 559–560. 2 indexed citations
14.
Yokoyama, M., Teruo Okano, Yu Sakurai, et al.. (1999). Selective Delivery of Adiramycin to a Solid Tumor Using a Polymeric Micelle Carrier System. Journal of drug targeting. 7(3). 171–186. 165 indexed citations
15.
Kikuchi, Akihiko, et al.. (1996). Controlled release of macromolecular dextran from calcium-alginate gel beads. 737–738. 5 indexed citations
16.
Miyazaki, Hiroaki, et al.. (1994). Water soluble polymer having phenylboronic acid moieties as synthetic mitogen. 23(3). 978–981. 3 indexed citations
17.
Suzuki, Kenichi, et al.. (1992). Intracellular calcium levels in platelets in contact with polymer surfaces and its implication with platelet activation pathway.. 21(1). 222–227. 1 indexed citations
18.
Tsuruta, Teiji, et al.. (1989). Separation of B and T lymphocytes by cellular adsorption chromatography with polyamine graft copolymers as column matrices. Biomaterials. 10(6). 393–399. 6 indexed citations
19.
Kataoka, Kazunori, et al.. (1988). Immunoaffinity chromatography of lymphocyte subpopulations using tert-amine derived matrices with adsorbed antibodies. Biomaterials. 9(3). 218–224. 27 indexed citations
20.
Sakurai, Yu, et al.. (1979). . KOBUNSHI RONBUNSHU. 36(4). 209–216. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026